Cardiovascular Institute researcher: Cancer drug may lower sudden cardiac death risk

February 24, 2014

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a new class of drugs, originally developed to treat cancer, reduces sudden cardiac death risk after a heart attack. The findings were published online in advance of print in the Journal of the American College of Cardiology.

"Currently, there are limited options to reduce following a ," said principal investigator Samuel C. Dudley, M.D., Ph.D., chief of cardiology at the CVI. "The benefit of most drugs is limited, and they have additional side effects. Defibrillators are an option, but they cannot be safely implanted for 40 days following a heart attack."

Dudley continued, "This finding gives us hope for a new treatment model, and if approved, will provide physicians with new options to lower patients' risk of death from cardiac arrest."

Approximately 525,000 people suffer a first heart attack, or , each year in the U.S., and there are an estimated 190,000 recurrent heart attacks each year. Following a heart attack, individuals are at an increased risk of sudden cardiac death (SCD).

In this study, researchers evaluated mice that had sustained a heart attack and also had abnormal heartbeats. The study found that inhibition of a protein signal known as c-Src decreased the risk of abnormal heartbeats and sudden cardiac death. This suggests usefulness of c-Src inhibition in preventing arrhythmias associated with heart failure. This use of Src inhibitors for treatment of sudden cardiac death risk has been submitted for a patent.

"More research is needed to evaluate the efficacy of this use of a cancer medication to alleviate risk of sudden cardiac death, but we are hopeful that what we observed in mice will translate effectively to humans, providing patients and clinicians with a new paradigm for treating this common and life-threatening illness," Dudley said.

Sudden (SCD) is an unexpected death caused by loss of heart function, or sudden . It is the most common cause of natural death in the U.S., resulting in approximately 325,000 adult deaths in the U.S. each year.

Explore further: Even moderate smoking associated with sudden death risk in women

Related Stories

Recommended for you

Researchers find sleep gene linked to heart failure

November 30, 2015

Researchers at the Stanford University School of Medicine have identified a gene that, when working properly, appears to reduce the risk of heart failure and improve treatment outcomes, highlighting a possible target for ...

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.